Table 1.
Clinical details of healthy control and patient with Parkinson disease
| Healthy subjects | Patient with Parkinson disease | |||
|---|---|---|---|---|
| Age (gender) | Age (gender) | UPDRS III (0–56) | H &Y (1–5) | Disease duration (years) |
| 74 (M) | 72 (M) | 9 | 1 | 6 |
| 43 (F) | 76 (M) | 5 | 1 | 7 |
| 75 (F) | 62 (M) | 23 | 1.5 | 7 |
| 80 (M) | 62 (M) | 23 | 2 | 10 |
| 58 (F) | 68 (F) | 26 | 2 | 14 |
| 61 (F) | 65 (F) | 9 | 1.5 | 4 |
| 83 (F) | 69 (M) | 25 | 2.5 | 10 |
| 77 (F) | 82 (M) | 32 | 2.5 | 7 |
| 79 (F) | 61 (F) | 18 | 1.5 | 3 |
| 61 (F) | 60 (F) | 26 | 2 | 20 |
| 78 (F) | 76 (M) | 20 | 2 | 10 |
| 74 (F) | 75 (M) | 32 | 2 | 10 |
| 82 (M) | 15 | 1 | 1 | |
| 46 (F) | 7 | 1 | 6 | |
| 63 (M) | 15 | 1 | 2 | |
| 75 (M) | 30 | 1.5 | 8 | |
| 70.25 (± 11.88) | 68.80 (± 9.43) | 19.69 (± 8.91) | 1.63 (± 0.53) | 7.81 (± 4.71) |